Free Trial
NASDAQ:PRE

Prenetics Global 4/1/2024 Earnings Report

Prenetics Global logo
$9.74 +1.65 (+20.40%)
As of 12:12 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Prenetics Global EPS Results

Actual EPS
-$0.52
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Prenetics Global Revenue Results

Actual Revenue
$5.43 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Prenetics Global Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Prenetics Global's next earnings date is estimated for Tuesday, June 17, 2025, based on past reporting schedules.

Conference Call Resources

Prenetics Global Earnings Headlines

Prenetics Global Limited (PRENW)
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are already using to their advantage… It allows them to treat this new asset like actual cash.
See More Prenetics Global Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Prenetics Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prenetics Global and other key companies, straight to your email.

About Prenetics Global

Prenetics Global (NASDAQ:PRE), a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.

View Prenetics Global Profile

More Earnings Resources from MarketBeat